ask="N/A"
ask_size="N/A"
average_daily_volume="203695"
bid="5.15"
bid_size="1400"
book_value="1.38"
change="+0.05"
change_from_200_day_moving_average="-1.09"
change_from_50_day_moving_average="-0.19"
change_from_52_week_high="-3.20"
change_From_52_week_low="0.90"
change_in_percent="+0.98%"
close="5.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.61"
ebitda="-55.83M"
eps_estimate_current_year="-1.25"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.09"
ex_dividend_date="N/A"
float_shares="42874000"
high="5.28"
high_52_weeks="8.35"
last_trade_date="2/2/2017"
last_trade_price="5.15"
last_trade_size="1984"
last_trade_time="4:00pm"
low="5.10"
low_52_weeks="4.25"
market_capitalization="298.39M"
moving_average_200_day="6.24"
moving_average_50_day="5.34"
name="Sorrento Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.00"
open="5.15"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-17.41%"
percent_change_from_50_day_moving_average="-3.63%"
percent_change_from_52_week_high="-38.32%"
percent_change_from_52_week_low="+21.18%"
previous_close="5.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.69"
price_per_sales="54.02"
revenue="5.47M"
shares_outstanding="57939000"
short_ratio="18.60"
stock_exchange="NCM"
symbol="SRNE"
volume="90347"
weeks_range_52="4.25 - 8.35"
